CLNS1A antibody: A304-521A


Antibody Info
Product_IDA304-521A
Lot_ID1
Host_organismrabbit
SourceBethyl Labs
Antibody_DCC_IDENCAB677WEY
Target Info
GeneNameCLNS1A
Phosphate
Target_nameCLNS1A-human

Validation Images
Cell linePrimary validationSecondary validation
HepG2 CLNS1A-HEPG2-CRISPR-A304-521A.png<br>Caption: Western blot following CRISPR against CLNS1A in HepG2 whole cell lysate using CLNS1A specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CLNS1A. CLNS1A protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow.

Caption: Western blot following CRISPR against CLNS1A in HepG2 whole cell lysate using CLNS1A specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CLNS1A. CLNS1A protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow.

Releated Sample: BGHcLV29-21

Status: Released

Lab: Graveley Lab

K562 Bethyl_A304-521A_1_CLNS1A.png<br>Caption: IP-WB analysis of K562 whole cell lysate using the CLNS1A specific antibody, A304-521A. Lanes 1 and 2 are 2.5% of five million whole cell lysate input and 50% of IP enrichment, respectively, using a normal IgG antibody. Lane 3 is 50% of IP enrichment from five million whole cell lysate using the CLNS1A-specific antibody, A304-521A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.

Caption: IP-WB analysis of K562 whole cell lysate using the CLNS1A specific antibody, A304-521A. Lanes 1 and 2 are 2.5% of five million whole cell lysate input and 50% of IP enrichment, respectively, using a normal IgG antibody. Lane 3 is 50% of IP enrichment from five million whole cell lysate using the CLNS1A-specific antibody, A304-521A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.

Comments: Immunoprecipitation lane (3) exhibits a large deviation from the expected protein size, which we believe is due to performing the characterization using the Jess Western Blotting system. This system has a documented tendency for some proteins to run differently than with more traditional methods due to their compositions and interactions with the electrophoretic components. The image also closely resembles the example image provided by the vendor. Our image closely resembles the vendor's image in which the band appears around 35kDa

Method: immunoprecipitation

Status: Released

Lab: Yeo Lab

CLNS1A-K562-CRISPR-A304-521A.png<br>Caption: Western blot following CRISPR against CLNS1A in K562 whole cell lysate using CLNS1A specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CLNS1A. CLNS1A protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow.

Caption: Western blot following CRISPR against CLNS1A in K562 whole cell lysate using CLNS1A specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CLNS1A. CLNS1A protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow.

Releated Sample: BGKcLV28-21

Status: Released

Lab: Graveley Lab